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Ectoplc sulomatic atrial Lnchycanlii, an ““oxlun0” type Of 
supraventricular tacbycardis n children and adutt5, baa 
been reported to be rfsistaot lo ntedical therapy, ad 
sur@l w rtyoabhWit has bnn recammendd. Tbii R 
putt describes 10 iolnnts and children (mfdlan age 6 
months: mnee birth to 7.5 vests) with automatic atrial 
five patients and oral prqwatt~ol successbdly cootroM 
tacbywdin In hvo of live t&r patieat3. class I auti- 
atrhytbmic agats+ulr.idii (three patient& prcaiua 
mide (four patkntr) nod phenyloio (three patiauts+iid 
nut caatml twhyurdia in any patkntp but male the 
Eclcpic automatic atrial tachycxdia is an uncommon type of 
supmventriculut tachycardia in the pediatric age group. 
Even though it is more commonly seen in children than 
adults, there are GO published repot& concerning children 
(I-IO). Clinical and electmphysiclogic features of ectopic 
atrial tachycardia n children and adults have been described 
by few investigators (1.2.6,11 JZ). Unlike reentrant supra- 
ventricular tachycardia, ectopic automatic atrial tacbycardia 
has been reported to be frequently refractory to medical 
therapy. and surgical or ctyoablation or electrical ablation 
have been recommended (I-5&19). The long-teno fol- 
tathy.xdia rate w- in lbree palieotr. lntn”cwus ,s 
mgikg per dase, and ord amiwe rnppd ta*bycar- 
dis in three of four patients and wal pmiodamoe sap- 
praed it in analher patient. 
Thus, iWawn0u.s pmptan&l and am&&one were 
elffaive in acutely suppressing autouu.tic ectopie Ptrial 
tacbycardis and predicted tiw respwlse to long-term orpl 
therapy. One patieat bad peRis,ent tacbycardia siter sw. 
$cal ablation of ti high rigtat ntrinl ectopic Lao, attd 
auuther patient had m catbcter ablatklu of the 
hi& right atrial ectcpie locus (25 J). Llmiog Wlw-up (10 
to 28 months), wtqlic atrial tachycar~is nwlvcd can- 
pwy in four palko(s and w* well mrltrclkd in four 
patients. 
(J Am Call Cardid 19.88;11:379-@ 
low-up of ectopic automatic atria1 tachycadia is limited. lo 
this report. we desctihe the clinical features, management 
and follow-up of 10 mfantr and children with ectopic PU~D- 
made atnal tachycardia. 
MIdhOdS 
Lkfbdtions. Ectopic automatic atrial tachycxdia was de- 
fined by three or more of the following criteria on either the 
surface electrocardiogram (ECG) or 24 b ambulatory ECG 
(Halter) recording (I.1 1.12): I  persistent atrial tachycxdia 
with inappropriate rate for the age; 2) variable rate and RR 
interval from minute to minute and hour to hour; 3) presence 
of a warm-up phase; 4) I’ wzw eoofigurdtion of the first heat 
of the tachrcardia identical to that of the subsequent beats of 
the tachycardia: and 5) tachycardia utta&cted by vagal 
otaneuvers. The iachycardia was confirmed by failure of 
induction or temtinaticn of tachycardia by standard elec- 
trophysiolcgic techniques and reset phenumena of the ecto- 
pit focus during atrial extrastimulus study (I.1 1.12). The 
tachycardia was further classified BS an incessant ype if it sedation was necessary. The methods of eiectrophysiologic 
was present for >9O% of the fimc or as a repetitive type if it study were the same as described by others (1.11.12). 
was frequent but unsustained. It was considered controlled Followup. The follow-up included a detailed history of 
or suppressed if the patient had nomtal sinus rhythm or the any symptoms or freqj ‘ncy of tachycardia. a record of 
Uchycardia rate was close to the sinus rate for age on 24 h medications taken. a I; ad surface ECG and 24 h Halter 
Halter recording during treatment with antiarrhythmic recording at least every 6 months in each patient 
agents. The patient was considered “cured” if. in the 
absence of antiarrhythmic therapy, no tachycardia was 
observed on two 24 b ambulatory Halter recordings obtained Results 
3 to 6 months apan. Clinical and ekxtrocardiogrsphic features (Table I). The 
Study patients. Between 1979 and 1985. IO patients were age at onset of tachycardia ranged from intrapartum to 7.5 
diagnosed to have ectopic automatic atrial tachycardia by years with a median age of 6 months. No pa+nt, except one, 
the described criteria. Patients with multifocal (chaotic) bad associated congenital cardiac defects or a family history 
atrial tachycardia were xcluded. Each patient was evalu- of supraventricular tachycardia. At initial presentation. five 
ated by detailed history, physical examination. I2 lead ECG, patients had clinical congestive heart failure as well as 
chest mentgenogram, M-mode and two-dimensional echo- diminished letl ventricular shortening fraction by echocar- 
cardiograms (9 of IO patients) and 24 h ambulatory Halter diography (<0.28). and one patienl had only a diminished 
recording. The tachycardia was documented both on I2 lead left ventricular shortening fraction. Each patient had nomml 
surface ECG and on 24 h H&r recording in each case. thyroid function. 
Each patient bad thyroid function tests to exclude thyrotox- &w&e ECG and 24 h H&r monitoring showed inces- 
icosis. sant tachycardia in six patients and repetitive tachycardia in 
Drug treatment pmtocol. After initial documentation of four. A wamt.up phase was observed in three of the four 
tachycardia. each patient received digitalis in therapeutic patients in whom initiation of the tachycardia was observed. 
dosage. Patients whose tachycardia was not suppressed by The maximal rate of atrial tachycardia >2lOlmin in all but 
diioxin were maintained on digoxin (0.01 to 0.015 mgikg Case 2. At initial presentation, all patients had I:I attioven- 
divided in tvto doses) and were given one or more of the tricular(AV) conduction with a narrow QRS complex during 
following drugs at different imes, either in the intensive care tachycardia. The tachycardia rate was variable from minute 
unit or during invasive ekctrophysioloaic study: intravenous to minute and with activitv in each case. Even though 
(0.1 mgIkg at I mg/min) DI L& prop~anolol iinitial dose 2 tachycardia rate increased si&ificantly with activity, ecto& 
m&g divided in 4doses). or both; intravenous (6 mgilrg over atrial tachycardia was noted during sleep in each case. 
5 min) or oral procainamide (initial dose 10 &kg divided in Distinct P waves were identified in each case with a normal 
4 doses), or both; quinidinc (initial dose IO &kg divided in PR interval and PRIRP ratio <I during tachycardia. The P 
4 doses): or ohenvtoin lmaintenance dose 5 ma/kg divided in wave wttfimtration of the first beat and subseauent beats of 
2 doses). If iach&rdi~ could not be contr&dwith these 
antiarrhytbmic agents, informed consent was obtained for a 
trial of intravenous (5 m&g wer 5 min) or qral amiodarone 
(IO m&for first week followed by a mqintqnance dose of5 
mglkg once a day). or both. Amicdamne wps given accord- 
ing to our experimental drug protocol, which was approved 
by the Committee for the Protection of Human Subjects in 
October 1981. Before a drug was considered to have failed, 
the dose was increased until there were clinical signs of 
toxicity or an elevated serum drug level. Diioxin therapy 
was continued in each patient until tachycardia was sup- 
pressed bv other zntiarrhvthmic aeents and left ventricular 
hysfuncti& improved. ’ - 
Ekctrophysiologie study. Cardiac catheterization and 
electrophysiologic study were performed in eight patients 
after informed consent was obtained. Each rratierd was 
the tachy&dia were similar in all. The P axiawas between 
0 and +W in eight cases. suggesting ahigh right atrial origin 
of the tachycardia and between 0 and -90” in two cases 
(Cases 2 and IO). suggesting a low right atria) origin of the 
tachycardia. 
EketrophysSogic study. The tachycardia could not be 
induced or terminated by rapid atrial pacing, atrial extrasti- 
mulus techniques or ventri&u extrastimulus techniques. 
The mechanism of tachycardia was of the automatic type as 
assessed by reported criteria (I ,I I. 12). By endocardial map- 
ping, the tachycardia originated from the high right atrium in 
six patients (high interatrial septum in three patients, high 
lateral wall of right atrium in two. high to mid-septum in one. 
atrial appendage in none) and from the low tight atrium in 
two patients, and its site of origin correlated with that 
identified bv the surface KG. In Palients 2 and IO. who had 
premedicaled with intramuscular meperidine h;drochloride a superior P wave axis during tachycardia, the tachycardia 
(2 m&g, maximtmt 50 mg), pmmethazine hydmchloride was neither induced nor terminated byprogrammed atrial or 
(0.5 &kg, maximum 12.5 mgl and chlorpromazine (0.5 ventricular extrastimulus techniques: and reset pbonemena 
m&8, maximum 12.5 mg) 30 mitt before the procedure; of the ectopic focus were noted during atria1 extrastimulus 
diazepam (0.1 mgikg) was given intravenously if additional study as described by others (1.11.12). Thus, paroxysmal 
reciprocaiingjunctional tachycardia was exclodcd in both of 
these eases. 
Management. Table I describes antiarrhythmic drug 
therapy in the order of its administration in each case. 
Diaoxin alone did not control the tachvcardia in anv oaticnt 
bui decreased the taehycardia rate by 5 to 2O%.in eight 
patients. Propranolol was administered to IO patients (Fig. 
I). Five patients (Cases 1, 4. 5. 6. and 91 initially received 
one dose of intravenous propranolol: three of these patients 
either developed nomtal sinus rhythm or had a tachycardia 
rate close to sinus rate for age and were subsequently well 
controlled on oral propranolol therapy. One of these patients 
(Case 5) hada2S%decrcase inthe tachycardia rate (16O/min) 
after intravenous propranolol but the tachycardia persisted 
during high dose oral therapy. Patient I had no significant 
effects from intravenous propranolol and treatment with oral 
propranolol was not started. No patient had any adverse 
efiects from the intravenous propmnolol. Ofthe five patients 
who received oral propranolol therapy (Casts 2. 3. 7.8 and 
IO) without a trial of intraveooos propranolol, two had good 
control of the tachycardia and three had no significant 
suppression of the tachycardia. other thnn variable AV 
block. Thus 5 of the IO patients were well controlled on oral 
propranolol therapy. 
cetople tachycardia disappeared in the catheterization lab+ 
ratory lfter intravenous procainamide. but tachycardia rc- 
corred in sm!e of hixh dose oral theraov. In anolher oatient 
(Case 5). brocainamide had no &&ant effect bn the 
tachycardn and oral therapy was not tried. In the other two 
patients (Cases I and IO). an increaSe in the tachycardia rate 
was noted and oral therapy was not started. No patient had 
hypotension or other adverse effects after intravenous pro- 
cainamide. Of three patients who received oral quinidine 
therapy (Cwcs 2 10 4) (Tables I and 2). quinidine had no 
signdicant effect on tachycardia in two patients and. in one 
patient ICase 4). the tachycardia rate worsened (Fig. 2). Oral 
phenytoin was unsuccessful in three patients (Cases 5.8 and 
101 in whom it was tried. Thus, class I antiarrhythmic agents 
were not helpful in any patients and worsened the tachycar- 
dia rate in three patients (Table 2). 
Amiodnrone ws tried infive parienrr Ores 1 IO 3.5 and 
8) (~8. I). Of four patients who received intravenous 
amiodarone. three either developed sinus rhythm or had a 
tachycardia rate close to sinus r&e for age and were well 
controlled on oral therapy; one patient (Case 3) had inter- 
mittent lachycardia after intravenous as well as oral amio- 
“Tb’ dial ventricular demand pacemaker was inserted. During I followup, she had persistent left ventricular dysfunction and 
died suddenly 3 months later. Patient I had unsuccessful 
transcatheter electrical ablation of the high lateral wall of the 
tigtd atrium with 25 j by a previously dcscribcd method (IS). 
F&w-up (Table 3). The follow-up period ranged be- 
tweeo 10 and 28 months (median 20). The tachycardia was 
completely resolved without drug therapy in four patients 
J I I (Cases 4, 5, 7 and IO). Patient 2 was well controlled with 
attic&row and Patient 8 was well controlled with amioda- 
rone and digoxin. Patient 9 hod a recurrent similar tachycar- 
Figore 1. Resells oftherapy with propranolol and amiodaone in IO 
patients with automatic ectopic atrial tacbycardia. Upper purl, 
respmse to intravenous and oral therapy with propranolol in 10 
patients. Lower panel. response of tachycardia to intravenous and 
oral therapy with emiodarone in five patients (see the text for 
dstailsl. SVT = wupraventricular tachycardia. 
darone therapy. No patient had adverse effects after iotta- 
venous amiodarone. Patient 5. who did not receive 
intravenous aotiodarooe, was well controlled on oral thcr- 
opy. Thus, four of the five patients were well controlled on 
oral amiodarooe theraw. Oral veraoaotil war tried in Patient 
2 and proved unsuccessful. 
Patient 3. who had interodttent tochycardia doting treat- 
ment with oral amioderone, had persistent similar tachycar- 
dia after surgical and cryoablation of the ectopic focus from 
the high posterior tight atrium, had unsuccessful surgical 
inductian of third degree AV block and a pertoooeot epicar- 
die when p~opronolol was discontinued after IO months of 
successful trial: ptopronolol therapy was restarted with good 
success. Patient I had recurrent lachycordia at a rate of 160 
to l7Olmin when digoxin and amiodarone were discontinued 
after L6 months of successful trial; this patient was subse- 
quently well controlled with digoxin therapy alone. Wtient 6 
was lost to follow up and Patient 3. with the permanent 
pacemaker, died suddenly at home. Left ventricular function 
improved in all except Case 3. Of five patients who 1 me 
maintained on long-term oral amiodarone therapy, Patients I 
and 2 had transient decrease of appetite and Patient 2 had a 
transient pmritic rash. None had Aeel microdeposits by 
slit lamp examination, thyroid dysfunction or pulmonary 
toxicity. 
Dkcussion 
C3ioical f&ores. These features of ectopic automatic 
atrial tachveardia have been described bv few investiaators 
(l-12). E&o thoogh ectopic atrial tachy&rdia otov present 
at any ae. it is predomioantlv seen in young infants and 
children.bur P&d 4 and thaiof Olsson et al.(il had onset 
oftachvcardia even before birth. A hmilv history of tachy- 
cordia has been reported with &topic at&l tech&dir+ a. 
but only one of our patients had such a family history. 
Unlike automatic junctional tachycardia the arrhythmia war 
not associated with congenital heart defects in any of oar 
patients. Left ventricular dysftmction has been reported 
commonly with ectopic atrial tachycardia. However, three 
of oar patients had neither clinical nor echocardiographic 
signs of left ventricular dysfunction at initial presentation, 
and all had improvement of left ventricular function atIer 
TaMI 1. Response of Suprercntricular Tacbyfardia to Three 
control of iochycardia. Our report soppans the hypothesis 
Class I Antiarrbytbmic Agents that myocardial dysfunction is a result rather than the cause 
E&et on Tachycardia 
of ectopic atria1 tachycardia (7-9). 
~___ Mffereollal diiosis. Like reentrattt supraventricular 
No. of No tochycardia in children, the rate of ectopic atrial tochycardia 
hue Patientr c0otra,kd EtTect wow may range between 200 and 3Wlmin. However, the variabil- 
tv p,c.ainamY I I I 1 ity of the tachycardia rate from minute to minute and hour to 
oral preaima+ I - I - hour, as noted in all cases. is extremely helpful in ditTeren- 
OnI puiwline 3 - I I 
oral phrnytmn , - 3 Ming ectopic atrial tachycardia from reentrant supraventri- _ cular tachycardia. The presence of a warm-up phase has 
tv = Inlra”e”o”r. been considered one of the diagnostic criteria for automatic 
electrophysiologic study is also necessary to exclude pi- 
tlents wilb paroxysmal junctional reciprocating tacbycardia. 
Medical therapy. In general, medical therapy has been 
dnappointing in the management of ectapic atrial tachycx- 
dia both in children and in adults tFIO,IZ-18). We and 
others (I-10) note that digoxin alone is not helpful in 
controlling ectopic atrial tachycardia but is probably bcnefi- 
clal in the temporary management ofcoexisting heart failure. 
Because automatic ectopic tachycardia is catecholamine 
sensitive. beta-adrenaceptar blocking agents have been tried 
in adults and children with variable success (I J.6). F’mpmn- 
olol was successful in 5 of our IO patients, especially younz 
inlants. In some re+wrts (10.17) pr~pranolol was not t&d 0; 
may have been administered in low doses because of ccex- 
isting heart fadure. Becaux of the same concern, all our 
patients were maintained on digoxin before propranolol 
therapy. In our series, five patients received both irmwe- 
nws and oral propranoloi therapy with a similar response to 
both mutes of administmtian without 2.1~ adverse effects. 
Because oral propranolol is a first pass drug. an acute trial of 
~mravenous proprarmlol can be helpful in predtcting the 
clinical response of ectopic atrial tachycardia to oral pm- 
pranolol as in our series. However. caution should be 
observed m patients with clinical or echocardiographic left 
ventricular dysfunction associated with chronic tachycardia. 
Even lhoupi~ class IA anriarrhylhmic agents, poniculurly 
quinidinr md pmcocninamide. are known to prolong atrial 
refractory periods and suppress automaticity, neither of 
these agents was successful in suppressing clinical tachycar- 
dia in our series. On the contrarv. the tachvcsrdia rate wa$ 
made worse by procainamide andquinidine in three patients. 
A similar response ofatriat txhycardia rate accelcmtion has 
been reported after intravenous verapamil therapy (IS). 
None of our patients had clinical toxicity or hypotensian 
secondary to procainamide or quinidine. which could pro- 
duce reflex sympathetic stimulation and worsen the rate of 
tachycardia. In any case. our study shows that quinidine and 
procainamide are not helpful in controlling ectopic arrial 
mchyc&dia. This is contradicted it? one report (S) but 
supported by ethers (7.9.10.13.15). Flecainide acetate. a 
class IC anlixrrhythsiic agent, has been reported successful 
in one patient (20). Ethm&n. a class IB antianhythmic 
went, is a derivative of phenotn;zine and SUPPESS~S ab- 
~&nl atrial automaticit;. Evans et al. illI r&&d that il 
successfully controlled automadc atria1 rachycxdia in four 
patients but the experience is still limited. 
Amiodnronr. a class Ill onriorrkyrhmic dgenl. was re- 
cently approved by the Food and Drug Administration in the 
Figure 1. Case 4. Representative lectrocardiogaphic rhythm strip 
from a newborn infant with ectopic atrial tachycardia. A. Uncon- 
trolled atrizl tachycardia at a mte of 16Olmin with variable atnown- 
tricnlc tA\r) conduction (partial AV block) on digoxin therapy. B. 
Increase in atrial tachycardia rate to 240lmin with digoxm and 
quinidine therapy. C, Sinus mchycardia at a rate of 1401mm with 
~ro~ranotot and digorin therapy. D, Normal kus rhvtbm 8, I vex 
of age in the absence of all drug therapy. 
ectopic tachycardia, but six of our patients had an incewant 
type of tachycardia and a warm-up phase was not observed. 
This sign was helpful only in patients with a repetitive type 
of tachycardia. As noted by Garson et al. (51 and in our 
series, the high right atrium appears to be the most summon 
site of origin ofectopic atrial tachycardia. In eight of our ten 
patients, the P wave during tachycardia was sinuslike and. in 
this setting, differentiation from sinus tachycardiais difficult. 
In this circumstance, the correct and early diagnosis of 
ectopic atrial tachycardia can be made by I) a high index of 
suspicion; 2) absence of factors predisposing to sinus tachy- 
cardia including thyrotoxicosis; 3) per&ent and insppropd- 
ate atrial tachycardia during steep on Hotter recording (as 
seen in all our cases), and 4 mesence of left ventricular 
dysfunction by echocardiograpiy in the absence of congen- 
ital heart disease. Our experience and that of others (1.2) 
suggest that the correct diagnosis of ectopic atrial tachycar- 
dia can be made by the clinical course. surface ECG and 24 
h Holter recording in mwt of the patients. 
Tabk 3. Results of Therapy on Follow-up m 1” Pa,,entr 
No s: >a& 
United States. Amiodarone orolottrs the atrial refractory antianhythmic agnts should be tried first and ablative 
period and suppresses atrial a~tontaticity. It also blacks the procedures hould be reserved for chronic r&tent tachy- 
eliects of svmrrathetic stimulation on the heart noncompeti- cardia with compromised myocardial function. 
lively (22): Skveral investigators (4,231 reported a good 
response of automatic atrial tachycardia to amiodarone. In 
our series, four patients received both intravenous and oral 
we ,hr”X JYIII crcggcr and Ll”di entree for lhdr CIpC” asrirtancc in 
prct)aramm or lhk ,nB”“IFripl. and Svzanne BrickIcy. George LVClS and 
amiodamne tbempy and one patient received only oral ,amer El”&. Eardlorarwlar ,cchnoladns. ror *ha, 8Plllla”ce wing a.- 
therapy; the response to oral therapy was similar to that of 
tmphylioloelc Ill dbl 
intravenous amiodarone, with good control of the tachycar- 
dia in four of the five patients. No patient had significant side 
effects from intravenous or oral amiodamne therapy. Thus. References 
our experience and that of others (6,231 suggest hat amio- 
darone is a good antiarrhythmic agent for the short- and 
tong-term manawnent of ectwic atrial tachycardia if con- 
vet&al antiar~hythmic age& fail. intravenous amioda- 
mne is also helpful in predicting the clinical response to oral 
amiodarone before a child is subjected to long-term oral 
amiodarone therapy. 
Ablative lherapy. Surgical resection of an ectopic focus, 
cryoablation apA surgical electrical ablation are recently 
described techniques in the management of automatic ecto- 
pit atria.1 tachycardia ~7.9.10,13-19). These invasive proce- 
dures appear to he an attractive alternative to long-term 
medical therapy. However, some problems with these SW- 
gical techniques need to be addressed. Before surgical 
ablation, invasive ekctrophysiologic mapping and inlraoper- 
ative mapping are necessary to identify accurately the site of 
an arrhythmogenic focus. Automatic ectopic atrial tacbycar. 
dia is sensitive to temcerature chanaes and anesthesia nd. 
unlike reentrant ach&ardia, may not be int:ueibk electri- 
cally, making intraoperative mapping impossi :le (161. Addi- 
tionally. Garsan et al. (5) recently reported a 50% recurrence 
risk of multiple ectopic foci after surgery for a single focus 
automatic ectopic atrial tachycardia. Recently. successful 
electrical ablation of the ectopic focus during Jectrophysio- 
logic study has been reported (15.19). However. this tech- 
nique is still new and has reported complications uch as 
perforation ofthe heart, thromhoembolism and sudden death 
(24.25). Therefore. ablative procedures hould be considered 
for patients whose ectopic atrial tachycardia proves refrac- 
tory to conventional and experimental antiarrhythmic 
agents. panicularly in the presence of compmmised ventri- 
cular function. Our ohservlions and those of others (I J.6) 14. Gil,cltcK.Garson Ah. Hesskin PS. eta,. S”ccaslf”tr”rgical WB nen, 
have shown that ectopic atrial tachycardia may resolve otfauiat. juncdaml and vrnlricvlar l chyrardn u as~&acd wh nccer 
spontaneously after I to 2 years of follow-up. espaially in sory con~~~lion~ in i rants and children. Am Hean J tW:t01.984-9t. 
young infants and children. Therefore. aggressive medical IS tMcttc PC. wampter DG. Oarson A Jr.. Zinner A. MI D. COW D. 
management is preferred before institution of any ablative 
Tratmmt of atrill ~“tomatic ta hycardis by ablafmn )rwedurer. I Am 
Call cardtot t9*1:6:4E-9. 
procedure. 16. 011 DA. Gilkne PC. Gano” A Jr. Caalry DA. Rd CI. McNamara DC. 
Clinical implications. Drugs like beta-adrenoceptor Su~icalmanagemrntofrdraitOryrupnv~ntriculartachyeardiainin~ntr 
blocking agents sod amiodarcne are effective in the control md cllwcn. J Am co,, cardio, 1981~12&9. 
of ectopic atrial tachycardia in children. The long-term 17. Andrrron KP. S,,nron Eta MasSa” JW. SYlgiCat cxEturio” of laal 
prognosis appears good with the possibility of spontaneous 
pProxysrnal til Mlycardia. *m J Cardiol ,9w9:86%71. 
resolution of the tachycardia. We believe the aggressive I*. Wyndham CRC. Amrdorf MF. Lwitsky S. ct al Sueearrfut rurgieal 
medical management with conventional and experimental 
lXEili0” Of focal paraxyrmal atria, tachycardla: *ervationr i” YRLl and 
in vilro. Circulatiw t980:62:t361-71, 

